Current filters:  
Life Sciences, Biotechnology & Nanotechnology
Davies Collison Cave
In the current COVID-19 environment, much of the innovation that we will require to tackle this pandemic will be borrowed from innovations of the past.
Davies Collison Cave
Special measures have been passed in Australia which exempt specified treatments for COVID-19 from requirements to be registered on the Australian Register of Therapeutic Goods (ARTG) prior to their supply.
Many Canadian import businesses have implemented remote working arrangements for employees as a result of COVID-19 government directives at the federal, provincial and municipal levels.
Bereskin & Parr LLP
Many life sciences companies have been willing to permit others to access their IP to help increase supply of equipment and development of new treatments during the COVID-19 pandemic.
Gowling WLG
In response to the unprecedented demand and urgent need for products to limit the spread and effect of the novel coronavirus (COVID-19)...
Miller Thomson LLP
A surge in global demand for emergency health and safety related goods is one of the outcomes of the COVID-19 pandemic.
Torys LLP
While the number and extent of the initial government programs and assistance intended to support Canadian companies in light of the fallout of the COVID‑19 pandemic is impressive...
Bereskin & Parr LLP
COVID-19 has brought about a global scramble for medical devices, such as personal protective equipment ("PPE") and diagnostic test kits.
Norton Rose Fulbright Canada LLP
Aux grands maux, les grands remèdes. Vous avez pu l'apprendre dans ces pages; l'arrêté d'urgence signé le 30 mars se veut un cadre légal exceptionnel, permettant à Santé Canada d'alléger le fardeau réglementaire ...
Norton Rose Fulbright Canada LLP
Health Canada recently published a notice to industry detailing its collaborations with international partners during the COVID-19 pandemic.
Global Advertising Lawyers Alliance (GALA)
As the direct impact of COVID-19 in China gradually subsides, the government has released the 2020 legislation plans and the working report for the first quarter of 2020.
創新医療機器特別審査制度の紹介 過日、医療機器の研究開発およびイノベーションを促進し、医療機器の新技術の普及および応用を推し๫
G. Vrikis & Associates LLC
Following the issue of Regulations ΚΔΠ 5229-5233 and ΚΔΠ 5239, the Minister of Labour, Welfare and Social Insurance issued on 2nd May 2020 Regulations ΚΔΠ 5257-5261 extending the provision of Special Leave Benefit...
European Union
Cooley LLP
This week, we take a closer look at issues relating to the supply and use of personal protective equipment ("PPE") in the context of the response to the COVID-19 crisis. The coronavirus outbreak continues to have...
Gun + Partners
The coronavirus (Covid-19) crisis has created extraordinary circumstances that require substantial additional resources and an increased availability of vitally important medical devices.
P+P Pöllath + Partners
On 20 May 2020, the German federal government passed into law the 15th Ordinance amending the Foreign Trade Ordinance (the 15th FTO Amendment).
Before any rules were notified for medical devices, they were being governed solely by the dated and redundant Drugs and Cosmetics Act, 1940 with no specific provisions or aspects pertaining to the regulation of medical devices in India.
For over a decade, software technologies have been bringing innovative changes and advancements in the healthcare sector, be it in monitoring, diagnosis, prevention or treatment of...
SSEK Indonesian Legal Consultants
Many businesses in Indonesia have been forced to temporarily cease their activities because of COVID-19. Some factories are still operating to ensure the continuation of production.
SSEK Indonesian Legal Consultants
Since the first COVID-19 case was reported in Indonesia on March 2, 2020, the number of cases has expanded to around 4,839 as of April 14, 2020, w
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Font Size:
Mondaq Social Media